Skip to main
NYXH

Nyxoah SA (NYXH) Stock Forecast & Price Target

Nyxoah SA (NYXH) Analyst Ratings

Based on 3 analyst ratings
Buy
Strong Buy 33%
Buy 67%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Nyxoah is poised for continued success as its product gains momentum in the U.S. market and with the pending completion of its ACCCESS study in 2026/2027, which could lead to label expansion. It has already exceeded initial expectations with 15 U.S. implants and 35 VAC approvals, and with a €77M financing secured, the company has the resources to continue its growth trajectory. Q3 revenues of €2.0M were in-line with expectations, showing solid performance and potential for increased profitability.

Bears say

Nyxoah is in a strong position with a successful 4Q25, but there are concerns about its long-term sustainability and potential competition in the sleep-disordered breathing market. The recent personnel changes provide a positive outlook, but there is still uncertainty surrounding the company's ability to drive consistent repeat orders and truly capture the market potential. Additionally, financial metrics such as revenue and profitability may not be able to fully support the company's valuation in the long run.

Nyxoah SA (NYXH) has been analyzed by 3 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 67% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Nyxoah SA and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Nyxoah SA (NYXH) Forecast

Analysts have given Nyxoah SA (NYXH) a Buy based on their latest research and market trends.

According to 3 analysts, Nyxoah SA (NYXH) has a Buy consensus rating as of May 6, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $9.33, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $9.33, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Nyxoah SA (NYXH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.